Osteosarcoma
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma
incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in …
incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in …
Recent advances in zinc oxide nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment
Simple Summary Despite breakthroughs in medicine, cancer remains one of the most feared
diseases. Traditionally, chemotherapies have been the treatment of choice. However …
diseases. Traditionally, chemotherapies have been the treatment of choice. However …
Osteosarcoma: a review of current and future therapeutic approaches
X Zhao, Q Wu, X Gong, J Liu, Y Ma - Biomedical engineering online, 2021 - Springer
Osteosarcoma (OS) is the most common primary bone malignancy that affects children and
young adults. OS is characterized by a high degree of malignancy, strong invasiveness …
young adults. OS is characterized by a high degree of malignancy, strong invasiveness …
A comprehensive review on barium titanate nanoparticles as a persuasive piezoelectric material for biomedical applications: prospects and challenges
Stimulation of cells with electrical cues is an imperative approach to interact with biological
systems and has been exploited in clinical practices over a wide range of pathological …
systems and has been exploited in clinical practices over a wide range of pathological …
Current and future therapeutic approaches for osteosarcoma
DJ Harrison, DS Geller, JD Gill, VO Lewis… - Expert review of …, 2018 - Taylor & Francis
Introduction: Current treatment of osteosarcoma includes surgical resection of all gross
disease in conjunction with systemic chemotherapy to control micro-metastatic disease. This …
disease in conjunction with systemic chemotherapy to control micro-metastatic disease. This …
Potential therapeutic targets of quercetin, a plant flavonol, and its role in the therapy of various types of cancer through the modulation of various cell signaling …
Polyphenolic flavonoids are considered natural, non-toxic chemopreventers, which are most
commonly derived from plants, fruits, and vegetables. Most of these polyphenolics exhibit …
commonly derived from plants, fruits, and vegetables. Most of these polyphenolics exhibit …
Future directions in the treatment of osteosarcoma
Future directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Future
directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Log in or Register …
directions in the treatment of osteosarcoma : Current Opinion in Pediatrics Log in or Register …
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival—a report from the Children's Oncology Group
PA Meyers, CL Schwartz, MD Krailo… - Journal of clinical …, 2008 - ascopubs.org
Purpose To compare three-drug chemotherapy with cisplatin, doxorubicin, and methotrexate
with four-drug chemotherapy with cisplatin, doxorubicin, methotrexate, and ifosfamide for the …
with four-drug chemotherapy with cisplatin, doxorubicin, methotrexate, and ifosfamide for the …
Therapeutic importance of kaempferol in the treatment of cancer through the modulation of cell signalling pathways
MY Qattan, MI Khan, SH Alharbi, AK Verma… - Molecules, 2022 - mdpi.com
Plant-derived flavonoids are considered natural nontoxic chemo-preventers and have been
widely studied for cancer treatment in recent decades. Mostly all flavonoid compounds show …
widely studied for cancer treatment in recent decades. Mostly all flavonoid compounds show …
Primary bone osteosarcoma in the pediatric age: state of the art
A Longhi, C Errani, M De Paolis, M Mercuri… - Cancer treatment …, 2006 - Elsevier
The current combination treatment, chemotherapy and surgery, has significantly improved
the cure rate and the survival rate of primary bone osteosarcoma. The 5-year survival rate …
the cure rate and the survival rate of primary bone osteosarcoma. The 5-year survival rate …